as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
1.44%
Downside
0.28%
Upside
52 Week's Low
52 Week's High
17.53%
Downside
6.94%
Upside
Check Edwards Lifesciences Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$45.5B
EPS (TTM)
2.5022
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.07%
PE Ratio (TTM)
32.46
Industry PE ratio
16.65525641025641
P/B Ratio
32.4561
PEG Ratio
4.2026
EBITDA
1.7B
Revenue (TTM)
5.7B
Profit Margin
72.96%
Return On Equity TTM
15.53%
Track how Edwards Lifesciences Corp. P/E has moved over time to understand its valuation trends.
Edwards Lifesciences Corp. in the last 5 years
Lowest (26.71x)
December 31, 2024
Industry (16.66x)
September 13, 2025
Today (32.46x)
September 13, 2025
Highest (52.31x)
December 31, 2021
Today’s Price to Earnings Ratio: 32.46x
Compare market cap, revenue, PE, and other key metrics of Edwards Lifesciences Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $45.5B | -5.15% | 32.46 | 72.96% | |
BUY | $152.2B | 154.93% | 61.14 | 13.55% | |
BUY | $146.6B | 89.75% | 50.77 | 12.25% | |
BUY | $232.8B | 27.73% | 16.78 | 32.43% | |
BUY | $120.6B | -10.25% | 25.98 | 13.63% |
The Edwards Lifesciences Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Edwards Lifesciences Corp. investment value today
Current value as on today
₹1,18,405
Returns
₹18,405
(+18.41%)
Returns from Edwards Lifesciences Corp. Stock
₹13,266 (+13.27%)
Dollar Returns*
₹5,139 (+5.14%)
Based on 40 analysts
60.00%
Buy
35.00%
Hold
5.00%
Sell
Based on 40 analysts, 60% of analysts recommend a 'BUY' rating for Edwards Lifesciences Corp.. Average target price of $87.73
Get share price movements and forecasts by analysts on Edwards Lifesciences Corp..
What analysts predicted
11.54%UPSIDE
Target Price
$87.73
Current Price
$77.61
Analyzed by
40 Analysts
Target
$87.73
Edwards Lifesciences Corp. target price $87.73, a slight upside of 11.54% compared to current price of $77.61. According to 40 analysts rating.
Search interest for Edwards Lifesciences Corp. Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Edwards Lifesciences Corp. has shown consistent revenue growth over the past four quarters, increasing from $1.35 billion to $1.53 billion. This represents an average quarterly increase of 4.0%.
Against Peers
In the last 1 year, Boston Scientific Corp. has given 23.3% return, outperforming this stock by 10.0%
Against Peers
In the last 3 years, Boston Scientific Corp. has given 143.4% return, outperforming this stock by 161.6%
Profit Down
Edwards Lifesciences Corp. has experienced a decline in net profit over the last four quarters. The profit dropped significantly from $3.07 billion to $329.8 million, averaging a decrease of 34.2% each quarter.
Price Dip
In the last 7 days, EW stock has moved down by -3.2%
Organisation | Edwards Lifesciences Corp. |
Headquarters | One Edwards Way, Irvine, CA, United States, 92614 |
Industry | Health Technology |
CEO | Mr. Bernard J. Zovighian |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Scott B. Ullem | Corporate VP & CFO |
Mr. Jean-Luc Lemercier | Corporate Vice President of Japan, Asia Pacific & Greater China |
Mr. Andrew M. Dahl | Principal Accounting Officer, Senior VP & Corporate Controller |
Mr. Dirksen J. Lehman | Corporate Vice President of Public Affairs |
Mr. Mark Wilterding | Vice President of Investor Relations |
Mr. Mark D. Peterson | Corporate VP & General Counsel |
Mr. Bernard J. Zovighian | CEO & Director |
Mr. Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development |
Mr. Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies |
Dr. Todd J. Brinton FACC, M.D. | Corporate VP of Advanced Technology & Chief Scientific Officer |
Edwards Lifesciences Corp. share price today is $77.61 as on at the close of the market. Edwards Lifesciences Corp. share today touched a day high of $77.83 and a low of $76.49.
Edwards Lifesciences Corp. share touched a 52 week high of $83 on and a 52 week low of $64.01 on . Edwards Lifesciences Corp. stock price today i.e. is closed at $77.61,which is 6.49% down from its 52 week high and 21.26% up from its 52 week low.
Edwards Lifesciences Corp. market capitalisation is $0.05T as on .
Indian investors can start investing in Edwards Lifesciences Corp. (EW) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Edwards Lifesciences Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Edwards Lifesciences Corp. share’s latest price of $77.61 as on September 13, 2025 at 1:29 am IST, you will get 0.1288 shares of Edwards Lifesciences Corp.. Learn more about
fractional shares .
Edwards Lifesciences Corp. stock has given -5.15% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?